Regenxbio Inc (RGNX)

R&D Expenses

$229.14M

TTM · Period ending: · USD

RGNX logo

RGNX R&D Expenses

Latest reported$229.14M
RGNX R&D Expenses ($5.05M → $229.14M)
High-resolution chart · PNG

RGNX r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regenxbio Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
228,299,000
208,522,000
232,266,000
242,453,000
181,437,000
166,294,000
124,185,000
83,873,000
57,224,000
45,482,000
17,279,000
4,961,000
5,051,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.